期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Epidemiology and outcome of individuals with intraductal papillary neoplasms of the bile duct 被引量:1
1
作者 Rong-Shou Wu Wen-Jun Liao +3 位作者 Jing-Sheng Ma jia-kun wang Lin-Quan Wu Ping Hou 《World Journal of Gastrointestinal Oncology》 SCIE 2023年第5期843-858,共16页
BACKGROUND Intraductal papillary neoplasm of the bile duct(IPNB)is a rare distinct subtype of precursor lesions of biliary carcinoma.IPNB is considered to originate from luminal biliary epithelial cells,typically disp... BACKGROUND Intraductal papillary neoplasm of the bile duct(IPNB)is a rare distinct subtype of precursor lesions of biliary carcinoma.IPNB is considered to originate from luminal biliary epithelial cells,typically displays mucin-hypersecretion or a papillary growth pattern,and results in cystic dilatation[1].IPNB develops anywhere in the intrahepatic and extrahepatic biliary tracts,and can occur in various pathological stages from low-grade dysplasia to invasive carcinoma.IPNBs have similar phenotypic changes in the occurrence and development of all subtypes,and the prognosis is significantly better than that of traditional(nonpapillary)cholangiocarcinoma.AIM To evaluate the clinicopathological features of IPNB to provide evidence-based guidance for treatment.METHODS Invasive IPNB,invasive intraductal papillary mucinous neoplasm of the pancreas(IPMN),and traditional cholangiocarcinoma data for affected individuals from 1975 to 2016 were obtained from the Surveillance,Epidemiology,and End Results(SEER)database.Annual percentage changes(APCs)in the incidence and incidence-based(IB)mortality were calculated.We identified the independent predictors of overall survival(OS)and cancer-specific survival(CSS)in indivi duals with invasive IPNB.RESULTS The incidence and IB mortality of invasive IPNB showed sustained decreases,with an APC of-4.5%(95%CI:-5.1%to-3.8%)and-3.3%(95%CI:-4.1%to-2.6%)(P<0.001),respectively.Similar decreases in incidence and IB mortality were seen for invasive IPMN but not for traditional cholangiocarcinoma.Both OS and CSS for invasive IPNB were better than for invasive IPMN and traditional cholangiocarcinoma.A total of 1635 individuals with invasive IPNB were included in our prognosis analysis.The most common tumor sites were the pancreaticobiliary ampulla(47.9%)and perihilar tract(36.7%),but the mucin-related subtype of invasive IPNB was the main type,intrahepatically(approximately 90%).In the univariate and multivariate Cox regression analysis,age,tumor site,grade and stage,subtype,surgery,and chemotherapy were associated with OS and CSS(P<0.05).CONCLUSION Incidence and IB mortality of invasive IPNB trended steadily downward.The heterogeneity of IPNB comprises site and the tumor’s mucin-producing status. 展开更多
关键词 Surveillance Epidemiology and End Results database Intraductal papillary neoplasms of the bile duct SUBTYPE Annual percentage changes Prognosis
下载PDF
外源添加产乙酸菌和酿酒酵母发酵物对瘤胃发酵特性及产乙酸菌菌群结构的影响(英文) 被引量:1
2
作者 Chun-lei YANG Le-luo GUAN +1 位作者 Jian-xin LIU jia-kun wang 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2015年第8期709-719,共11页
目的:酵母可以促进产乙酸菌利用氢生成乙酸。为了解产乙酸菌在瘤胃发酵中的作用,本试验研究了产乙酸菌单独添加及其与酿酒酵母发酵物联合添加对瘤胃发酵特性及产乙酸菌菌群结构的影响。创新点:通过瘤胃甲烷生成量与产乙酸菌菌群结构关联... 目的:酵母可以促进产乙酸菌利用氢生成乙酸。为了解产乙酸菌在瘤胃发酵中的作用,本试验研究了产乙酸菌单独添加及其与酿酒酵母发酵物联合添加对瘤胃发酵特性及产乙酸菌菌群结构的影响。创新点:通过瘤胃甲烷生成量与产乙酸菌菌群结构关联,揭示降低瘤胃甲烷生成的新途径。方法:试验采用2×2双因素试验设计,产乙酸菌TWA4的添加量为0和2×107 cells/ml,酿酒酵母发酵物XP的添加量为0和2 g/L。结论:瘤胃体外发酵研究发现,单独添加XP以及TWA4和XP联合添加可增加挥发性脂肪酸产量(P<0.05),TWA4和XP联合添加显著增加了甲烷生成量(P<0.05)。单独添加TWA4、XP以及两者联合添加均增加了含有甲酰四氢叶酸合成酶的微生物的数量,尤其是产乙酸菌的数量,这类微生物的增长幅度高于产甲烷菌。各处理产乙酸菌均以Lachnospiraceae为主,但与已培养的微生物的相似性较低。与Acetitomaculum ruminis低相似性的一类未知的产乙酸菌在各处理中均占优势,但XP的添加增加了与Eubacterium limosum低相似未知产乙酸菌的数量。与XP不同,TWA4及其与XP的联合添加使与A.ruminis低相似性的一类未知的产乙酸菌的数量增加,与E.limosum低相似未知产乙酸菌的数量降低。因此,添加与E.limosum低相似的未知产乙酸菌和(或)酵母可能是降低瘤胃甲烷生成的一种有效途径。 展开更多
关键词 产乙酸菌 酿酒酵母发酵物 瘤胃发酵 产甲烷菌
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部